GPCRdb

MESPIPERONE

Agent/drug
Bioactivity

MESPIPERONE

SMILES	CN1CN(c2ccccc2)C2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O
InChIKey	QHJLPOSPWKZACG-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors	4
Hydrogen bond donors	0
Rotatable bonds	6
Molecular weight (Da)	409.2

Database connections

ChEMBL_compound_ids PubChem GPCRdb
Ligand site mutations	D₂ D₄

Bioactivities

Affinity
Potency

Search:

Receptor					Activity				Source

Protein	Gene	Species	Family	Class	Type	Min	Avg	Max	Database

5-HT_2A	5HT2A	Human	5-Hydroxytryptamine	A	pKi	8.06	8.06	8.06	ChEMBL
D₂	DRD2	Rat	Dopamine	A	pKi	9.93	9.93	9.93	ChEMBL
D₂	DRD2	Rat	Dopamine	A	pKd	10.01	10.01	10.01	ChEMBL
D₂	DRD2	Human	Dopamine	A	pKd	10.01	10.01	10.01	ChEMBL
D₂	DRD2	Human	Dopamine	A	pKi	9.88	9.88	9.88	ChEMBL
D₃	DRD3	Human	Dopamine	A	pKi	9.58	9.58	9.58	ChEMBL

Showing 1 to 6 of 6 entries

Search:

Receptor					Activity				Source

Protein	Gene	Species	Family	Class	Type	Min	Avg	Max	Database

α_1A	ADA1A	Rat	Adrenoceptors	A	pIC50	8.00	8.00	8.00	ChEMBL
D₂	DRD2	Rat	Dopamine	A	pIC50	9.64	9.64	9.64	ChEMBL

Showing 1 to 2 of 2 entries

MESPIPERONE

Drug properties

Molecular type	Small molecule
Physiological/Surrogate	Surrogate
Approved drug	No

Distribution across phases (no. indications)

Phase I 0

Phase II 0

Phase III 0

Phase IV

Database connections

ChEMBL_compound_ids PubChem GPCRdb
Ligand site mutations	D₂ D₄

Compound is not listed as a drug.